澳大利亚蜜蜂花粉的抗过敏特性
Chie Watanabe1, Taichi Mitsui2, Satoshi Uchiyama2
1Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.
Bioscience, biotechnology, and biochemistry
|March 28, 2025
概括
澳大利亚蜜蜂花粉有效地抑制了 hialuronidase 的活性和白血 B4 的释放. 这种功能性食物显示出抗过敏性质,减少了几内亚猪鼻炎模型中的鼻分泌物.
科学领域:
- 阿皮疗法是一种治疗疗法.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 蜜蜂花粉是一种蜜蜂养殖产品,作为一种功能性食物得到了认可.
- 之前的研究确定了基胺酸胺基 (HCAAs) 和黄类化合物是澳大利亚蜜蜂花粉的主要成分.
- 蜜蜂花粉的抗过敏潜力需要进一步研究.
研究的目的:
- 评估澳大利亚蜜蜂花粉提取物及其主要化合物的有效性.
- 为了确定对 Hyaluronidase 活性和白血 B4 (LTB4) 释放的抑制作用.
- 在临床前模型中评估澳大利亚蜜蜂花粉的抗过敏特性.
主要方法:
- 进行了体外测试,以测量蜜蜂花粉提取物和分离化合物的抑制氨酶活性和LTB4释放.
- 基胺酸胺基 (HCAAs) 和黄类被分析为关键成分.
- 用一个几内亚猪鼻炎模型来研究体内抗过敏效应.
主要成果:
- 高酸氨基酸显示出显著抑制氨基酶活性和LTB4释放.
- 在几内亚猪鼻炎模型中,服用澳大利亚蜜蜂花粉提取物有效抑制了鼻分泌.
- 这些发现表明,澳大利亚蜜蜂花粉具有强大的抗过敏特性.
结论:
- 澳大利亚蜜蜂花粉具有显著的抗过敏特性,归因于其HCAA含量.
- 证明了氨基酶和LTB4释放的抑制,支持其治疗潜力.
- 澳大利亚蜜蜂花粉是一种有希望的功能性食品成分,用于管理过敏症.
相关概念视频
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Cross-reactivity
Overview
Allergic Reactions
Overview
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...


